
U.S. Fentanyl Tariff: A Misguided Blame Game?
The U.S. imposed tariffs on Chinese imports over fentanyl flows, deflecting from its domestic opioid crisis and risking key counter-narcotics cooperation.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
The U.S. imposed tariffs on Chinese imports over fentanyl flows, deflecting from its domestic opioid crisis and risking key counter-narcotics cooperation.
Chinese Consul General Zhang Jianmin criticizes U.S. tariffs based on the fentanyl issue, warning of negative impacts on global trade and local economies.
China criticizes the US for imposing tariffs on Chinese goods under the pretext of fentanyl concerns, labeling it an unjustified move and announcing countermeasures.
China’s Foreign Ministry urges the U.S. to engage in equal talks on fentanyl and warns against bullying tactics, emphasizing mutual respect and cooperation in addressing shared concerns.
China’s State Council Information Office releases a white paper detailing the “1+5+N” narcotics laboratory network, reinforcing its global stance on fentanyl control.
China’s Foreign Ministry spokesperson Lin Jian denounces the U.S. for blaming China for its fentanyl crisis while highlighting China’s efforts to support the U.S. in combating the issue.
China responds to new U.S. tariffs with WTO complaint, urging dialogue to stabilize relations and safeguard global economic stability.
China’s Public Security Ministry strongly opposes U.S. 10% tariffs on imports, citing rigorous drug control policies and highlighting the importance of bilateral cooperation.
The US imposes 10% tariffs on China to combat the opioid crisis, but experts argue that addressing domestic demand and fostering international cooperation are key to reducing overdose deaths.
US tariffs on fentanyl imports from China clash with WTO rules, raising concerns about multilateral trading stability.